Recent News for IGXT - Intelgenx Technologs

Date Title
Sep 3 IntelGenx to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Aug 9 IntelGenx (IGXT) Reports Q2 Loss, Misses Revenue Estimates
Aug 8 IntelGenx Reports Second Quarter 2019 Financial Results
Aug 1 IntelGenx to Report Second Quarter 2019 Financial Results on August 8, 2019 – Conference Call to Follow
Aug 1 Will IntelGenx (IGXT) Report Negative Q2 Earnings? What You Should Know
Jul 10 IntelGenx to Present at 12th Edition of Clinical Trials on Alzheimer’s Disease
Jun 19 IntelGenx Announces Addition of Peterborough’s Kawartha Centre as Montelukast VersaFilm® Phase 2a Clinical Trial Site
Jun 10 IntelGenx Announces Addition of Ottawa Montelukast VersaFilm® Phase 2a Clinical Trial Site; First Patient in Study Completes 26-Week Treatment
May 28 IntelGenx Receives First Shipment of Cannabis Extract from Tilray® for Production of Cannabis-Infused Oral Film
May 23 IntelGenx to Join the Quebec Pavilion at BIO 2019 International Convention
May 9 IntelGenx: 1Q Earnings Snapshot
May 9 IntelGenx Reports First Quarter 2019 Financial Results
May 8 IntelGenx Announces the Appointment of André Godin as President and Chief Financial Officer
May 8 IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil
May 2 IntelGenx to Report First Quarter 2019 Financial Results on May 9, 2019 – Conference Call to Follow
May 1 IntelGenx Announces Issuance of Second U.S. Patent for Topical Oral Film Technology
Apr 25 IntelGenx to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
Apr 23 IntelGenx to Promote Oral Films CDMO Services at CPhI North America
Apr 16 IntelGenx Files Non-Provisional U.S. Patent Application for Oil-Based Active Ingredients
Apr 8 IntelGenx to Promote VetaFilm™ Oral Film Technology at Human Biotech & Animal Health Business Partnering Summit
Apr 4 IntelGenx Presents at 14th International Conference on Alzheimer’s and Parkinson’s Disease
Apr 2 IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA
Mar 27 IntelGenx Grants Stock Options
Mar 22 IntelGenx Reports Fourth Quarter and Full-Year 2018 Financial Results
Mar 18 IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 25, 2019 – Conference Call to Follow
Back to the Main IGXT Page...